SAVA

Cassava Sciences Stock Price

71.15
-32.20 (-31.16%)
Upgrade to Real-Time
Afterhours (Closed)
71.15

Low
2.78

52 Week Range

High
146.16

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Cassava Sciences Inc SAVA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-32.20 -31.16% 71.15 19:59:20
Open Price Low Price High Price Close Price Prev Close
88.00 65.00 95.15 69.53 103.35
Bid Price Ask Price Spread News
71.01 71.19 0.18 - 1
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
263,884 25,195,106 $ 79.40 $ 2,000,466,347 - 2.78 - 146.16
Last Trade Time Type Quantity Stock Price Currency
19:59:17 formt 200 $ 71.15 USD

Period:

Draw Mode:

Cassava Sciences Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 2.85B 40.01M 37.92M $ - $ - -0.25 -466.60
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -53.97k 5.80%

more financials information »

Cassava Sciences News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical SAVA Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week124.50146.1665.00114.347,523,510-53.35-42.85%
1 Month89.40146.1665.00107.204,771,552-18.25-20.41%
3 Months41.68146.1636.050388.153,106,55029.4770.71%
6 Months20.50146.1619.0166.834,663,76350.65247.07%
1 Year3.30146.162.7836.154,985,02767.852,056.06%
3 Years1.21146.161.0025.283,245,77669.945,780.17%
5 Years1.21146.161.0025.283,245,77669.945,780.17%

Cassava Sciences Description

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms.
Your Recent History
NASDAQ
SAVA
Cassava Sc..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210731 00:20:51